ALL THE KING S MEN. Falls Mitigation THE ULTIMATE FALLS REDUCTION BELIEF

Similar documents
Safe Prescribing of Drugs with Potential for Misuse/Diversion

Rational prescribing in the older adult. Assoc Prof Craig Whitehead

MMG003 GUIDELINES FOR THE USE OF HYPNOTICS FOR THE TREATMENT OF INSOMNIA

Fall Prevention in Hospice (A pharmacologic and nonpharmacologic approach)

Managing Fear of Cancer Recurrence: Coping with Fear and Uncertainty After Cancer

SUMMARY OF PRODUCT CHARACTERISTICS FOR BENZODIAZEPINES AS ANXIOLYTICS OR HYPNOTICS

Psychotropic Medication. Including Role of Gradual Dose Reductions

COMMON DRUG RELATED PROBLEMS SEEN IN PACE AND MECHANISMS TO MITIGATE RISK

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly

Package leaflet: Information for the user. Zolpidem Vitabalans 10 mg film-coated tablets zolpidem tartrate

PROCEDURE REF NO SABP/EXECUTIVE BOARD/0017

Anxiolytic and Hypnotic drugs

Black holes taped on floor Redirection Music and activities Yellow straps across the door Remind other residents to use call bell when she comes in

WHAT IS CHRONIC PAIN? ADVICE THAT WILL HELP MOST PATIENTS AND REDUCE THE NUMBER OF RETURN VISITS:

Awareness, Love and Light. Our Story

POLYPHARMACY. A practical approach to deprescribing in care homes. Care Home Pharmacy Team. Herts Valleys Clinical Commissioning Group

Medicine purposes and side effects

Raritan Bay Medical Center

Xanax dosage for alcohol withdrawal

Management of Delirium in Hospice Patients

Zopiclone Orion. Date: , Version 1.2 PUBLIC SUMMARY OF THE RISK MANAGEMENT PLAN

Dealing with Depression

PACKAGE LEAFLET. Page 1 of 8

PACKAGE LEAFLET: INFORMATION FOR THE USER DIAZEPAM 5mg/ 10mgRECTAL SOLUTION

MEDICATION MANAGEMENT AGREEMENT Pain Management Program Participation Agreement and Consent

ALZHEIMER S DISEASE, DEMENTIA & DEPRESSION

LECTOPAM PRODUCT MONOGRAPH. bromazepam. 3 mg and 6 mg Tablets. Anxiolytic - Sedative. Date of Revision: September 6, 2018

Updates to CMS SOM rules on Psychosocial Issues, Deficiency Categorization, and Psychotropic Medication Use

European PSUR Work Sharing Project CORE SAFETY PROFILE. Lendormin, 0.25mg, tablets Brotizolam

Primary Diagnosis YES NO ICD - Code Cancer Cognitive impairment Cardiac Respiratory Neurological Musculoskeletal Respiratory Other

Xanax and anxiety panic attacks

Eventscape: The Aural Experience of Space and Place

Psychotropic Strategies Handout Package

Polypharmacy: Guidance for Prescribing in Frail Adults

Addressing Difficult Behaviors in Dementia

HA CONVENTION Effectiveness of Pharmacist-led Frail Elderly Medication Service in Acute Geriatric Ward

CONTENTS SECTION 1 SECTION

If a bad thing is happening to a patient, a drug did it until proven otherwise

Appendix 1. University of Minnesota Amplatz Children s Hospital Opioid Weaning Guideline

Who has Schizophrenia? What is Schizophrenia? 11/20/2013. Module 33. It is also one of the most misunderstood of all psychological disorders!

Lorazepam Tablets, USP

DRUGS THAT ACT IN THE CNS

Schizophrenia is a serious mental health condition that affects

Polypharmacy in the Elderly

The cancer of mental illness

Medications Contributing to Falls. Kate Niemann, PharmD BCGP AuBurn Pharmacy

Summary of Delirium Clinical Practice Guideline Recommendations Post Operative

M0BCore Safety Profile. Active substance: Bromazepam Pharmaceutical form(s)/strength: Tablets 6 mg FR/H/PSUR/0066/001 Date of FAR:

Anxiety Disorders. Fear & Anxiety. Anxiety Disorder? 26/5/2014. J. H. Atkinson, M.D. Fear. Anxiety. An anxiety disorder is present when

Prevention of Medication-Related Falls Through Appropriate Medication Use. Clay Sprouse, MEd., CPhT Piedmont Technical College

SCHIZOPHRENIA AN OVERVIEW

Responding to The Joint Commission Alert on Safe Use of Opioids in Hospitals

Briefing Document on Medication use and Falls

A Step Forward: Promoting Independence through Falls Prevention

Dementia and Fall Geriatric Interprofessional Training. Wael Hamade, MD, FAAFP

INFORMED CONSENT FOR OPIOID TREATMENT FOR NON-CANCER/CANCER PAIN Texas Pain and Regenerative Medicine

Blueprint for Prescriber Continuing Education Program

Dissociative Disorders. Dissociative Amnesia Dissociative Identity Disorder Depersonalization-Derealization Disorder

Guidelines for the Management of Behavioural and Psychological Symptoms of Dementia (BPSD) Summary document for Primary Care

RELEVANT ACUTE TRUST LOGO WORKING IN PARTNERSHIP WITH

Medication Information for Parents and Teachers

Package leaflet: Information for the user. Zopiclone Orion 7.5 mg film-coated tablets. zopiclone

ENSURING EXCELLENCE IN PRESCRIBING FOR OLDER ADULTS

Revolutionizing Cost Management... One Person at a Time.

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

PACKAGE LEAFLET: Information for the patient. DIAZEPAM Tablets 5 mg Solution for injection 10 mg / 2 ml (Diazepam)

ABCs of Dementia & Caregiving

Mental health and older people

BODY SYSTEMS, DRUGS, AND OBSERVATIONS SCOPE OF UNIT: This unit includes guidelines for observing and reporting.

Zyban SR tablets bupropion hydrochloride Consumer Medicine Information (CMI)

Quick guide to autism

Choosing Wisely Psychiatry s Top Priorities for Appropriate Primary Care

Understanding late stage dementia Understanding dementia

Deconstructing Polypharmacy. Alan B. Douglass, M.D. Director

Managing Behaviors: Start with Yourself!

ABCs of Dementia & Caregiving. PET and Aging. As We Age, WE DO NOT lose function in our Brains, UNLESS. Something Goes Wrong with Our Brains

Anxiolytic, Sedative and Hypnotic Drugs. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Benzodiazepines: risks, benefits or dependence

The Prescription Review Program and College Expectations. Dr. Rashmi Chadha MBChB MScCH CCFP MRCGP Dip. ABAM

Opiate Use Disorder and Opiate Overdose

Who are Aging Life Care Professionals?

Using the ASCP-NCOA Falls Risk Reduction Toolkit Part 1: A Companion to CDC's STEADI Toolkit

Communication with Cognitively Impaired Clients For CNAs

Behavioral Issues in Dementia. March 27, 2014 Dylan Wint, M.D.

Medication Management. Medications: The Right Balance. Who are we talking about? Geriatric Syndromes 9/19/2016. Older adults are a heterogenous group!

Psychological Disorders

AN INTEGRATED APPROACH TO BENZODIAZEPINE DISCONTINUATION: SHARED MEDICAL APPOINTMENTS FOR VETERANS CO-PRESCRIBED OPIOIDS AND BENZODIAZEPINES

Medication Treatment of Cognitive and Behavioral Symptoms in Dementia

Benzodiazepines and Hypnotics

The Basics of Psychoactive/Psychotropic Medications Tina Sanchez, RN, SMQT New Mexico Department of Health Division of Health Improvement State

Managing Care at End of Life:

Pain Self-Management Strategies Wheel

July We hope that our tool will be a useful aid in your efforts to improve pain management in your setting. Sincerely, 7/14

Women, Aging and Mental Health. Dr Cathy Shea Associate Professor Head, Division of Geriatric Psychiatry University of Ottawa

The 6 Vital Keys to Turn Visualization Into Manifestation

Tofranil and Tofranil-PM (imipramine)

Patient Agreement for the use of Opioid Medications

Medication Use in Older Adults

A Primer on Safe Prescribing to the Elderly. Dr. John Puxty

Metformin Hydrochloride

Transcription:

ALL THE KING S MEN Falls Mitigation THE ULTIMATE FALLS REDUCTION BELIEF ANSWERS TO FALLS MITIGATION LIES IN YOUR ABILITY TO LOOK INSIDE OF THE PERSON S REALITY - - - - T SOLELY AT EXTERL THINGS THE GOAL MUST BE TO DETERMINE THE PERSON S GOAL FOR MOVING OR GETTING UP AND THEN HELPING THEM MEET IT. COGNITIVE FUNCTIOL AGE ASSESSMENT ALLEN-Levels www.allen-cognitivelevels.com RCCT www.clocktestrcct.com DEFINITION OF CHALLENGING BEHAVIOR Whose Problem Is it? What is Non-compliance? presented by Diana Waugh MOMENTS IN MIND 4/15/10 Page 1

PLAGUES OF THE ELDERLY Boredom Loneliness Helplessness STRENGTHS OF THE CONFUSED ELDERLY REPETITIVE, N-THINKING BEHAVIORS PHYSICAL ACTIVITY SENSE OF RHYTHM HOARDING LONG TERM MEMORY HUMOR PHYSICAL/EMOTIOL HEALTH CAUSES OF BEHAVIORS ENVIRONMENTAL TASK SPECIFIC COMMUNICATION presented by Diana Waugh MOMENTS IN MIND 4/15/10 Page 2

ASSESSMENT OF BEHAVIORS Eleven W s WHO has the challenge WHAT is the challenge WHY address it WHAT happens before WHERE does it happen WHAT does it mean WHEN does it occur WHAT is the pattern WHO is around when it happens WHAT is the usual outcome WHAT is the desired outcome ABCs Antecedents to Behavior Behavior Consequences presented by Diana Waugh MOMENTS IN MIND 4/15/10 Page 3

SOCIAL ASSESSMENT What does the person like to: See Smell Taste Touch Hear Three stories that make the person happy Three topics/issues that make the person unhappy What do they like to do What is their favorite chair Where do they like to sit Where are they sleeping How long do they sleep Why do they get up presented by Diana Waugh MOMENTS IN MIND 4/15/10 Page 4

MEDICATION REVIEW This form can be used with the health care professionals to review the role of medications in falls. The sections marked Pharmacy can be used for pharmacists input also. MEDICATIONS Person receives one or more of the following medications: Analgesic Antianxiety Agent Anticonvulsant Antidepressant Antihistamines Antihypertensive Antiparkinson Agent Antipsychotic Agent Diuretic Hypoglycemics Muscle Relaxant Nonsteroidal Anti-Inflammatory Sedative/Hypnotic MEDICATION CONSUMPTION ISSUES Has the dosage form changed? Is the person taking the med at different times each day? Is the med being crushed sometimes and not others? Is a non-crushable med being crushed? _ Is the med being given either with food or without food as directed? presented by Diana Waugh MOMENTS IN MIND 4/15/10 Page 5

TIME OF FALL RELATED TO MEDICATION ADMINISTRATION Was a potential causer PRN med taken within the last 12 hours? Are any bedtime meds interfering with sleep, and possibly causing bedtime sedation? Are multiple sedative mediations given at bedtime causing hangover effects at time of fall? What is the peak action time of a suspected med? (Pharmacist) What may be the cumulative effect of the peak action of several meds? (Pharmacist) What are the peak action times of antidiabetic meds? (Pharmacist) What are the blood glucose readings at these peak action times? DOSE CHECK OF NEW MEDS Is this a typical geriatric dose (Pharmacist) If dose is high, was dose gradually achieved? If higher, was size of person taken into consideration? (Pharmacist) _ POST WITHDRAWAL MED EFFECTS _ Was a recently discontinued med stopped abruptly? _ Should the recently discontinued med have been tapered? (Pharmacist) _ Is the side effect of the discontinued med similar to the side effects of a new overlapping med? (Pharmacist) _ presented by Diana Waugh MOMENTS IN MIND 4/15/10 Page 6

VITAL SIGNS Are the blood pressures noted during typical times of incidents? Does the blood pressures fluctuate at different times of the day? Does blood glucose fluctuate during the day? What were blood pressures within a week before fall? If diabetic, what were blood glucose readings one week before the fall? SIDE EFFECTS EVALUATION Is the description of the personʼs condition before the fall clear? Is a suspected med side affect a likely factor? RECOMMENDATIONS Recommend continuation of current med regime? (Pharmacy) Recommend changes to the current med regime as follows: (Pharmacy) _ presented by Diana Waugh MOMENTS IN MIND 4/15/10 Page 7